Targeted screening of atrial fibrillation using automated blood pressure measurement device with atrial fibrillation detection function, in patients with type 2 diabetes mellitus in primary care setting

Table 1 Characteristics of recruited patients

	Total (n = 2015)
Age, mean ± SD, years	66.4 ± 10.6
Female sex—no. (%)	1082 (53.7)
Body mass index, mean ± SD	25.5 ± 4.06
Smoker—no. (%)	169 (8.4)
Hypertension—no. (%)	1698 (84.3)
Duration of DM, mean ± SD, years	8.7 ± 7.9
Latest HbA1c level, mean ± SD (%)	6.9 ± 0.9
Congestive heart failure—no. (%)	15 (0.7)
Prior stroke or transient ischaemic attack—no. (%)	126 (6.3)
History of vascular disease (prior MI/PVD/aortic plague)—no. (%)	28 (1.4)
Previous history of AF—no. (%)	33 (1.6)
CHA₂DS₂-VASc score mean ± SD	3.3 ± 1.3

CHA₂DS₂-VASc score (C: congestive heart failure [1 point]; H: hypertension [1 point]; A2: age 65–74 years [1 point] and age ≥ 75 years [2 points]; D: diabetes mellitus [1 point]; S: prior stroke or transient ischaemic attack [2 points]; VA: vascular disease [1 point]; and Sc: sex category [female] [1 point])

ISSN: 2466-1171